This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Aortic hypoplasia
Q17_AORTIC_HYPOPLASIA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
48 |
4. Check minimum number of eventsNone |
48 |
5. Include endpointsNone |
48 |
6. Filter based on genotype QC (FinnGen only) |
43 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Aortic hypoplasia
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of great arteries
- Left ventricular outflow tract obstruction, narrow definition
- Left ventricular outflow tract obstruction (LVOTO), broad definition
- Congenital malformations of heart and great arteries
- Congenital malformations of the circulatory system
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 43 | 21 | 22 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 0.14 | 0.14 | 0.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
27
55
10.77
14.94
39.9
9.9
82.93
91.76
%
0.92
27
55
23
42
10.16
13.80
7.1
8.6
177.52
174.17
%
0.08
23
42
31
83
9.79
13.12
35.5
8.6
36.75
31.56
s
1.42
31
83
32
90
9.85
12.88
6.3
4.2
—
—
—
0
0
34
129
7.69
9.29
7.0
4.8
—
—
estimate
—
0
0
24
66
6.65
9.27
18.6
7.0
2.28
2.32
mg/l
0.01
18
51
10
7
17.83
6.76
3.5
5.1
5.37
4.73
kpa
—
10
7
10
7
17.83
6.76
3.5
5.1
6.46
5.97
kpa
—
10
7
9
6
18.24
6.19
3.1
2.2
100.89
99.33
g/l
—
9
6
14
25
7.62
5.99
55.2
54.6
16.11
15.21
%
0.67
14
25
15
30
6.95
5.94
54.0
33.5
24.80
24.52
mmol/l
0.16
15
30
19
60
4.75
5.87
21.0
22.7
107.68
105.82
mmol/l
0.83
19
60
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
19
8.18
5.53
90.3
19.2
0.30
0.33
iu/ml
—
5
13
13
24
7.16
5.43
50.6
47.5
115.31
118.58
g/l
0.21
13
24
11
17
8.17
5.15
6.4
4.2
80.00
106.88
%
1.71
11
17
14
31
6.07
5.12
56.9
32.5
97.43
96.35
%
1.17
14
31
14
31
6.07
5.12
56.9
32.4
0.65
0.67
%
0.08
14
31
14
32
5.86
4.99
56.9
31.5
0.89
1.14
%
0.90
14
32
14
35
5.32
4.62
57.9
42.8
18.14
16.58
kpa
0.46
14
35
14
35
5.32
4.62
57.9
42.7
5.31
5.47
kpa
0.40
14
35
37
230
4.41
4.23
32.2
16.7
6.14
5.97
mmol/l
0.32
37
220
45
358
+∞
4.09
43.6
21.7
139.24
139.34
mmol/l
0.14
45
351
45
360
+∞
3.85
43.4
21.4
4.03
4.01
mmol/l
0.17
45
350
26
138
3.09
3.36
8.1
11.2
23.50
23.44
mmol/l
0.07
26
138
9
21
5.08
3.19
2.4
3.0
—
—
—
0
0
11
32
4.21
3.17
8.5
25.2
0.66
0.59
%
0.27
11
32
7
12
6.67
3.15
1.1
1.9
—
—
—
0
0
14
53
3.38
3.15
2.3
2.3
—
—
—
0
0
45
375
+∞
3.15
27.7
13.9
53.29
52.45
umol/l
0.10
45
367
11
33
4.07
3.08
8.5
24.5
1.00
1.16
%
0.48
11
33
11
33
4.07
3.08
8.1
24.0
117.64
121.09
g/l
0.23
11
33
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
5
11.01
3.05
1.6
1.0
155.20
138.40
%
—
5
5
34
218
3.29
3.03
42.0
23.1
1.19
1.23
mmol/l
2.78
34
212
13
50
3.25
2.83
2.3
2.1
—
—
—
0
0
13
51
3.18
2.73
2.2
2.0
—
—
—
0
0
8
20
4.62
2.71
2.6
3.0
11.25
10.05
%
—
8
20
14
61
2.88
2.45
8.4
3.7
382.00
337.77
u/l
0.09
14
61
5
8
6.85
2.43
3.8
4.5
24.80
20.13
umol/l
—
5
8
26
159
2.50
2.30
40.0
18.2
25.08
24.87
mmol/l
0.19
26
159
5
10
5.47
2.13
16.2
3.7
549.20
190.37
ug/l
—
5
10
25
156
2.36
2.05
9.9
9.5
112.50
108.57
ml/min/173m2
0.41
18
114
5
13
4.18
1.76
1.4
1.8
—
—
—
0
0
6
19
3.48
1.72
2.5
1.9
—
—
—
0
0
6
20
3.30
1.64
2.5
1.9
—
—
—
0
0
11
52
2.48
1.60
20.8
5.8
350.09
322.00
u/l
0.17
11
52
6
22
2.98
1.49
1.7
1.7
—
—
—
0
0
0
39
0.00
1.42
0.0
1.5
—
—
—
0
0
5
18
2.99
1.32
1.4
1.2
—
—
—
0
0
5
19
2.83
1.25
1.6
1.2
—
—
—
0
0
28
212
1.85
1.12
12.5
6.5
130.89
149.70
u/l
0.51
28
199
9
46
2.19
1.12
4.1
7.2
284.33
261.24
umol/l
—
9
46
17
234
0.56
1.02
4.0
2.7
5.44
5.46
mmol/l
0.04
17
214
14
202
0.55
0.98
2.8
2.5
—
—
—
0
0
34
382
0.55
0.81
3.7
4.2
—
—
—
0
0
5
24
2.21
0.77
1.6
1.6
—
—
—
0
0
14
101
1.56
0.59
2.6
2.6
1.43
1.11
mmol/l
0.56
14
93
5
82
0.56
0.52
1.6
2.3
—
—
—
0
0
5
84
0.55
0.51
1.6
2.4
—
—
—
0
0
5
33
1.58
0.43
1.8
1.9
—
—
—
0
0
0
16
0.00
0.42
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
14
172
0.73
0.36
7.6
4.6
74.21
66.48
nmol/l
0.63
14
161
16
130
1.36
0.35
3.3
4.1
2.71
2.37
mg/l
0.47
16
114
17
195
0.79
0.24
5.3
3.8
34.47
36.20
mmol/mol
0.61
17
186
5
41
1.25
0.23
3.4
2.4
—
—
—
0
0
24
216
1.24
0.22
3.9
3.7
1.37
1.40
mmol/l
0.14
24
204
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
24
217
1.23
0.21
4.0
3.7
2.50
2.61
mmol/l
0.26
24
206
23
246
0.87
0.12
6.9
5.0
6.61
7.33
mm/h
0.14
23
236
17
159
1.11
0.06
3.2
5.5
—
—
—
0
0
11
116
0.93
0.01
11.9
3.2
2.41
2.43
mmol/l
0.12
11
109
5
53
0.94
0.00
1.4
1.2
0.10
3.07
u/ml
—
5
45
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
39
390
1.00
-0.00
56.2
22.0
334.49
335.53
g/l
0.36
39
390
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
52
0.96
-0.00
1.4
2.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
30
300
1.00
-0.00
20.6
13.1
4.48
3.45
e9/l
0.98
25
242
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
112.40
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
1.66
—
0
7
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.7
—
261.33
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
0.63
—
0
6
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
1.04
—
0
7
0
7
0.00
-0.00
0.0
5.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
57
0.86
-0.00
1.6
2.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_AORTIC_HYPOPLASIA – Aortic hypoplasia
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).